Cover Image

Latency reactivating agents: impact on human macrophages physiology and susceptibility to HIV-1 infection

Saved in:

Bibliographic Details
Main Authors:	L. Hany (Author), M.-O. Turmel (Author), C. Barat (Author), M. Ouellet (Author), M.J. Tremblay (Author)
Format:	Book
Published:	Elsevier, 2019-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The steroid receptor coactivators are targets for reactivation of HIV latency
by: B.C. Nikolai, et al.
Published: (2015)

Galectin-1 promotes HIV-1 latency reactivation
by: J. Rubione, et al.
Published: (2019)

Reactivation capacity by latency reversing agents ex vivo correlates with the size of the HIV-1 reservoir
by: Gilles Darcis, et al.
Published: (2016)

23 Understanding the effects of latency reversing agents on HIV RNA splicing: implications for latency reversal
by: T.M. Mota, et al.
Published: (2016)

Combinatorial latency reversal activity of inhibitor of apoptosis antagonists with mechanistically distinct classes of HIV latency reversal agents
by: Shane D. Falcinelli, et al.
Published: (2019)

The efficacy and tolerability of latency-reversing agents in reactivating the HIV-1 reservoir in clinical studies: a systematic review
by: Quinten Debrabander, et al.
Published: (2023)

Patient-derived HIV reservoirs can be stably engrafted into NSG mice and reactivated by latency-reversing agents in vivo
by: A. Ward, et al.
Published: (2017)

O6 Reactivation capacity by latency reversing agents ex vivo correlates with the size of the HIV-1 reservoir
by: Gilles Darcis, et al.
Published: (2016)

Optimisation of Smac mimetics as HIV-1 latency reversing agents
by: L. Pache, et al.
Published: (2019)

Visualisation of HIV reactivation from latency in primary resting memory T-cells
by: F. Kizito, et al.
Published: (2019)

21 Patient-derived HIV reservoirs can be stably engrafted into NSG mice and reactivated by latency-reversing agents in vivo
by: Adam Ward, et al.
Published: (2017)

Insights into mechanisms of HIV reactivation from latency using RNA-Seq gene expression profiling in CD4+ T cells and their maturation subsets following treatment with latency reversing agents.
by: N. Beliakova-Bethell, et al.
Published: (2017)

Maraviroc reactivates HIV with a potency similar to that of other latency reversing drugs without inducing toxicity in CD8 T cells
by: S. Moreno, et al.
Published: (2019)

Differential effects of HIV latency-reversing agents on T cell phenotype and function: implications for HIV cure
by: G. Clutton, et al.
Published: (2015)

Leishmania infantum amastigotes enhance HIV-1 production in cocultures of human dendritic cells and CD4 T cells by inducing secretion of IL-6 and TNF-alpha.
by: Ravendra Garg, et al.
Published: (2009)

4 New HIV specific latency reversing agents with novel targets that synergise with HIV Tat and the bromodomain inhibitor, JQ1 to reactivate HIV from primary cells.
by: J. Jacobson, et al.
Published: (2017)

Degradation of the XPB subunit of TFIIH by spironolactone reduces HIV-1 reactivation from latency
by: L. Mori, et al.
Published: (2019)

Identification of isoform-selective hydroxamic acid derivatives that potently reactivate HIV from latency
by: Elleard F.W. Heffern, et al.
Published: (2019)

Mixed effects of HDACi on host gene expression and their implications for HIV reactivation from latency
by: N. Beliakova-Bethell, et al.
Published: (2015)

OP 2.8 - 00193 Enhancing PKC Modulator HIV Latency Reversing Agents
by: M. Marsden, et al.
Published: (2022)

Human endogenous retrovirus expression landscape in models of HIV-1 latency
by: M. de Mulder Rougvie, et al.
Published: (2019)

Tissue-specific effects of latency-reversing agents on HIV transcriptional blocks in gut and blood
by: S. Telwatte, et al.
Published: (2019)

OP 8.2 - 00033 Interleukin-2 administration is a potent latency reversal agent in people with treated HIV infection
by: M. Freeman, et al.
Published: (2022)

Using single-cell analysis and a primary model of HIV to study latency establishment and reactivation
by: L. De Armas, et al.
Published: (2019)

Approaches to discover latency-reversing agents
Published: (2015)

Novel use of alprazolam as a potential HIV-1 latency reversing agent
by: W. Elbezanti, et al.
Published: (2017)

Latency-reversing agents and cellular activation affect antigen processing in primary CD4 T cells
by: J. Boucau, et al.
Published: (2015)

PP 5.4 - 00184 Optimization of Smac Mimetics as HIV-1 Latency Reversing Agents
by: L. Pache, et al.
Published: (2022)

An unbiased platform to identify regulators of HIV latency in infected primary human CD4 T Cells
by: U. Rathore, et al.
Published: (2019)

OA2-1 Frequent and 'burst-like' reactivation from latency in SIVmac239M infected macaques
by: M. Pinkevych, et al.
Published: (2016)

Memory CD4+ T cell subsets show differential responses to HIV latency-reversing agents
by: D.A. Kulpa, et al.
Published: (2015)

O3 Heme-arginate as a latency-reversing agent for HIV-1 cure
by: Michaela Madlenakova, et al.
Published: (2017)

Defining the Effects of PKC Modulator HIV Latency-Reversing Agents on Natural Killer Cells
by: Melanie Dimapasoc, et al.
Published: (2024)

30 Changes in expression of small non-coding RNA during HIV infection and latency in a CD4+ T cell model of HIV latency
by: SaiVikram Vemula, et al.
Published: (2017)

Interactions with pathogenic bacteria induce HIV-1 latency in macrophages through altered transcription factor recruitment to the LTR
by: T. Hanley, et al.
Published: (2019)

SMAC mimetics are potent latency reversal agents with single agent and combination activity ex vivo
by: R.M. Dunham, et al.
Published: (2017)

Identification of a promising new class of latency reversing agents
by: A. Gramatica, et al.
Published: (2017)

Evaluation of HIV latency reversal using designed PKC modulators in humanized BLT mice
by: M.D. Marsden, et al.
Published: (2015)

Induction of HIV from latency by a novel molecule
by: N.M. Archin, et al.
Published: (2015)

PP 2.13 - 00160 Enhancing Tolerability and Efficacy of Latency Reversing Agents in "Kick and Kill" HIV Cure Approaches
by: J. Moran, et al.
Published: (2022)